Page last updated: 2024-11-07

n-acetyl-s-(2-cyanoethyl)cysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-acetyl-S-(2-cyanoethyl)cysteine: major urinary metabolite of acrylonitrile; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114812
CHEBI ID165879
MeSH IDM0085250

Synonyms (22)

Synonym
nascs
(2r)-2-acetamido-3-(2-cyanoethylsulanyl)propanoic acid
n-acetyl-s-(2-cyanoethyl)-cysteine
74514-75-3
CHEBI:165879
l-cysteine, n-acetyl-s-(2-cyanoethyl)-
(2r)-2-acetamido-3-(2-cyanoethylsulfanyl)propanoic acid
s-cyanoethylmercapturic acid
q710t40465 ,
unii-q710t40465
n-acetyl-s-(2-cyanoethyl)cysteine
n-acetyl-s-(2-cyanoethyl)-l-cysteine
s-(2-cyanoethyl)mercapturic acid
l-cysteine,n-acetyl-s-(2-cyanoethyl)-
AKOS030240840
n -acetyl-s-(2-cyanoethyl)-l-cysteine
DTXSID70996027
s-(2-cyanoethyl)-n-(1-hydroxyethylidene)cysteine
Q27287069
discontinued. please see a172083
n-acetyl-s-(2-cyanoethyl)cysteine ammonium salt
s-(2-cyanoethyl)mercapturic acid ammonium salt

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Urinary CEMA levels show a clear dose-response relationship with daily cigarette consumption and urinary cotinine."( A column-switching liquid chromatography-tandem mass spectrometry method for quantitation of 2-cyanoethylmercapturic acid and 2-hydroxyethylmercapturic acid in Chinese smokers.
Gao, N; Hou, H; Hu, Q; Tang, G; Xiong, W; Zhang, X, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
N-acyl-L-amino acidAny N-acylamino acid having L-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (41.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (50.00)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.75 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]